Clinical Trial Update: Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and tolerability of macitentan in subjects with combined pre- and post-capillary pulmonary hypertension due to left vent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Macitentan (macitentan)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2019-05-15